Does IPILIMUMAB Cause Myocarditis? 475 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 475 reports of Myocarditis have been filed in association with IPILIMUMAB (YERVOY). This represents 1.3% of all adverse event reports for IPILIMUMAB.
475
Reports of Myocarditis with IPILIMUMAB
1.3%
of all IPILIMUMAB reports
182
Deaths
304
Hospitalizations
How Dangerous Is Myocarditis From IPILIMUMAB?
Of the 475 reports, 182 (38.3%) resulted in death, 304 (64.0%) required hospitalization, and 148 (31.2%) were considered life-threatening.
Is Myocarditis Listed in the Official Label?
Yes, Myocarditis is listed as a known adverse reaction in the official FDA drug label for IPILIMUMAB.
What Other Side Effects Does IPILIMUMAB Cause?
Death (3,710)
Malignant neoplasm progression (3,296)
Diarrhoea (2,557)
Off label use (2,097)
Colitis (1,988)
Pyrexia (1,796)
Rash (1,556)
Fatigue (1,447)
Intentional product use issue (1,329)
Nausea (1,169)
What Other Drugs Cause Myocarditis?
CLOZAPINE (1,702)
PEMBROLIZUMAB (1,060)
NIVOLUMAB (959)
OLANZAPINE (425)
ATEZOLIZUMAB (372)
CARBOPLATIN (325)
QUETIAPINE (315)
MESALAMINE (272)
BEVACIZUMAB (230)
PACLITAXEL (225)
Which IPILIMUMAB Alternatives Have Lower Myocarditis Risk?
IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE
IPILIMUMAB vs IPRATROPIUM
IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS
IPILIMUMAB vs IPTACOPAN
IPILIMUMAB vs IRBESARTAN